Advertisement

ASO Author Reflections: Non-GIST Sarcoma Liver Metastasis: How to Use the Past and Present to Predict the Future

  • Claire Goumard
  • Claudius Conrad
ASO Author Reflections

Notes

Disclosure

The author has no conflicts of interest to disclose.

References

  1. 1.
    1. Jo VY, Doyle LA. Refinements in sarcoma classification in the current 2013 world health organization classification of tumours of soft tissue and bone. Surg Oncol Clin North Am. 2016;25(4):621–43.CrossRefGoogle Scholar
  2. 2.
    Choi H. Role of imaging in response assessment and individualised treatment for sarcomas. Clin Oncol. 2017; 29:481–8.CrossRefGoogle Scholar
  3. 3.
    3. Stacchiotti S, Verderio P, Messina A, Morosi C, Collini P, Llombart-Bosch A, et al. Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer. 2012;118(23):5857–66.CrossRefGoogle Scholar
  4. 4.
    4. Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, Tzeng CD, Chun YS, Feig BW, Vauthey JN, and Conrad C. Long-term survival according to histology and radiologic response to preoperative chemotherapy in 126 patients undergoing resection of non-GIST sarcoma liver metastases. Ann Surg Oncol. 2018;25(1):107–16CrossRefGoogle Scholar
  5. 5.
    Therasse P, Le Cesne A, Van Glabbeke M, Verweij J, Judson I. RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma. Eur J Cancer. 2005;41(10):1426–30.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Surgical Oncology, Hepato-Pancreato-Biliary SurgeryThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations